Acta Scientific Cancer Biology (ASCB) (ISSN: 2582-4473)

Editorial Volume 5 Issue 2

Lung Cancer©

Andrew Hague*

Professor of Advanced Medicine, President of Cell Sonic Limited, England, UK

*Corresponding Author: Andrew Hague, Professor of Advanced Medicine, President of Cell Sonic Limited, England, UK.

Received: December 29, 2020; Published: November 30, 2020


The ease with which cancer is stopped by CellSonic surprises oncologists and delights patients. Cancer is an electrical fault. The behaviour of the cells is corrected by changing the voltage to that of healthy cells, a process called electroporation. There is no surgery and no drugs. This is biophysics, not biochemistry. There are no side effects and the replication of mutating cancer cells is stopped immediately. Then starts the healing of the damage caused by cancer and the usual problems in patients unfortunate to have been treated with chemotherapy and radiation.





Citation: Andrew Hague. “Lung Cancer©”. Acta Scientific Cancer Biology 5.2 (2021): 01-03.


Acceptance rate35%
Acceptance to publication20-30 days
Impact Factor1.183

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 30, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US